The value of pharmaceuticals--some direction for employers.

Ronnie Goetzel, Ronald J. Ozminkowski, David C. Schutt

Research output: Contribution to journalArticle

Abstract

The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.

Original languageEnglish (US)
Pages (from-to)31-35
Number of pages5
JournalEmployee benefits journal
Volume27
Issue number3
StatePublished - 2002
Externally publishedYes

Fingerprint

Health Priorities
Drug Costs
Consultants
Cost-Benefit Analysis
Organizations
Costs and Cost Analysis
Research
Pharmaceutical Preparations
Therapeutics
Direction compound

Cite this

The value of pharmaceuticals--some direction for employers. / Goetzel, Ronnie; Ozminkowski, Ronald J.; Schutt, David C.

In: Employee benefits journal, Vol. 27, No. 3, 2002, p. 31-35.

Research output: Contribution to journalArticle

Goetzel, R, Ozminkowski, RJ & Schutt, DC 2002, 'The value of pharmaceuticals--some direction for employers.', Employee benefits journal, vol. 27, no. 3, pp. 31-35.
Goetzel, Ronnie ; Ozminkowski, Ronald J. ; Schutt, David C. / The value of pharmaceuticals--some direction for employers. In: Employee benefits journal. 2002 ; Vol. 27, No. 3. pp. 31-35.
@article{837676cf3bca4b9eb5c5425fc096c6df,
title = "The value of pharmaceuticals--some direction for employers.",
abstract = "The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.",
author = "Ronnie Goetzel and Ozminkowski, {Ronald J.} and Schutt, {David C.}",
year = "2002",
language = "English (US)",
volume = "27",
pages = "31--35",
journal = "Employee benefits journal",
issn = "0361-4050",
publisher = "International Foundation of Employee Benifit Plans",
number = "3",

}

TY - JOUR

T1 - The value of pharmaceuticals--some direction for employers.

AU - Goetzel, Ronnie

AU - Ozminkowski, Ronald J.

AU - Schutt, David C.

PY - 2002

Y1 - 2002

N2 - The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.

AB - The costs of drugs keep rising. Are they worth it? Employers should consider value over cost, and make decisions based on diagnostics and research. They should thoroughly examine their organizations' experience to determine high-priority health conditions and do cost-effectiveness studies (using experienced consultants if necessary) that focus on all of the consequences of conditions and indicate the best medical and pharmaceutical therapies to treat them. Doing so should produce both human and financial dividends.

UR - http://www.scopus.com/inward/record.url?scp=0036717943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036717943&partnerID=8YFLogxK

M3 - Article

C2 - 12219561

AN - SCOPUS:0036717943

VL - 27

SP - 31

EP - 35

JO - Employee benefits journal

JF - Employee benefits journal

SN - 0361-4050

IS - 3

ER -